Assignment of Sublicenses. Upon termination of this AGREEMENT, LICENSEE’s interest in sublicenses granted by it under this AGREEMENT shall at UNIVERSITY’s sole option, terminate or be assigned to UNIVERSITY, including the right to receive income from SUBLICENSEES. LICENSEE shall make provision for UNIVERSITY’s rights under the preceding sentence to be included in all sublicenses granted by it under this AGREEMENT.
Assignment of Sublicenses. If this Agreement is terminated prior to Term pursuant to Section 2.2, then Licensee shall seek to promptly assign all of its right, title, and interest to all sublicenses to Licensor, including the right to receive all income from Sublicensees. Licensee shall expressly include this requirement as part of any sublicense agreement.
Assignment of Sublicenses. Upon request by a Sublicensee, and at CIHS’s discretion, a sublicense granted by NEWLINK under the Licensed Patents and Licensed Technology shall remain in effect and be assigned to CIHS in the event this Agreement terminates, but only to the extent such sublicense is consistent with the terms of this Agreement and is not in breach thereof.
Assignment of Sublicenses. Endocyte shall take all steps reasonably necessary to terminate each Sublicense, effective as of the date of termination of Endocyte’s license from PRF under this Agreement. Upon request of Endocyte and Sublicensee and verification by Sublicensee that Endocyte is not in default of any obligation to Sublicensee, and in PRF’s sole discretion, PRF may accept assignment of a Sublicense, including the right to all consideration promised to Endocyte thereunder. Notwithstanding anything contained in this Agreement to the contrary, PRF shall not be bound by any of the following with respect to a Sublicense: (1) duties or obligations of Endocyte to Sublicensee which cannot be assumed or performed by PRF because they are inconsistent with applicable laws or policies then in effect; (2) duties or obligations of Endocyte that exceed the obligations of PRF as licensor in this Agreement; and/or (3) duties or obligations of Endocyte contained in any Sublicense that are not contained in this Agreement, or which extend beyond the Term.
Assignment of Sublicenses. The Terminating Party(ies) shall use commercially reasonable efforts to assign to Tanox any applicable sublicenses to the extent related to Active Products and/or subcontracts relating to significant services to be performed by Third Parties to the extent related to Manufacture, Development or Commercialization of Active Products, as reasonably requested by Tanox, and Tanox shall perform all of the applicable Terminating Party’s obligations under each such sublicense in so far as they relate to the Active Product.
Assignment of Sublicenses. Genentech shall use commercially reasonable efforts to assign to Novartis any applicable sublicenses to the extent related to Active Products and/or subcontracts relating to significant services to be performed by Third Parties to the extent related to Manufacture, Development or Commercialization of Active Products, as reasonably requested by Novartis, and Novartis shall perform all of Genentech’s obligations under each such SCHEDULE D sublicense after the effective date of such assignment in so far as they relate to the Active Product.
Assignment of Sublicenses. Novartis shall use commercially reasonable efforts to assign to the applicable Assignee any applicable sublicenses to the extent related to Active Products and/or subcontracts relating to significant services to be performed by Third Parties to the extent related to Manufacture, Development or Commercialization of Active Products, as reasonably requested by the applicable Assignee, and the applicable Assignee shall perform all SCHEDULE D of Novartis’ obligations under each such sublicense after the effective date of such assignment in so far as they relate to any Anti-IgE Antibody or Anti-IgE Product.
Assignment of Sublicenses. Upon termination of this Agreement, Licensee agrees to assign to Licensor all its rights under the Sublicense Agreements granted under this Agreement. All Sublicense Agreements shall contain the provision that Licensee may assign the Sublicense Agreements to Licensor if this Agreement is terminated; provided that Licensor shall not be required to accept such an assignment and may terminate any such Sublicense Agreement without obligation or liability to Licensee or its Sublicensee if (i) Licensee has not complied with the requirements of Article 2.4 (Rights to Sublicense) of this Agreement; (ii) if such Sublicense Agreement does not comply with Article 2.4 of this Agreement, or (iii) if Sublicensee is in breach of their Sublicense Agreement.
Assignment of Sublicenses. Any sublicenses granted by MBI of the rights it receives under Section 5.1, including any nonexclusive sublicenses, will remain in effect and, at MBI’s election, may be assigned to USNY if the license in Section 5.1 terminates pursuant to Article 12, provided the financial obligations of each Sublicensee to USNY will be at least the same as the Sublicensee’s obligations to MBI with respect to Licensed Patent Rights but, in any event, will not be less than MBI’s obligations to USNY for such sublicenses under this Agreement and provided that USNY has been provided with a copy of any sublicense agreement, USNY finds the terms of such agreement reasonably acceptable and any Sublicensee to be assigned agrees to comply with all of the terms of this Agreement. For avoidance of doubt, USNY may reject assignment of a sublicense if USNY reasonably concludes that MBI or the Sublicensee has not provided adequate assurance of the capability of the Sublicensee to satisfy the financial obligations of this Agreement. In such event and subject to the preceding sentences, and provided that any such Sublicensees are not barred from contracting with the State of New York, USNY will assume all the rights and obligations of MBI under such sublicenses with respect to the licenses granted under the Licensed Patents Rights and other Technology Rights to such Sublicensees. In the event of such assignment, unless otherwise agreed by USNY, USNY will not be obligated to assume any obligation of MBI under the license agreement other than the granting of the license rights consistent with the terms hereof.
Assignment of Sublicenses. Any sublicenses granted by MOI of the rights it receives under Section 5.1, including any nonexclusive sublicenses, will remain in effect and, at MOI’s and KHH’s election, may be assigned to KHH if the license in Section 5.1 terminates pursuant to Article 13, provided the financial obligations of each Sublicensee to KHH will be at least the same as the Sublicensees’ obligations to MOI with respect to Licensed Patent Rights but, in any event, will not be less than MOI’s obligations to KHH for such sublicenses under this Agreement. In such event and subject to the preceding sentence, KHH will assume all the rights and obligations of MOI under such sublicenses with respect to the licenses granted under the Licensed Patents Rights and other Technology Rights to such Sublicensees. In the event of such assignment, unless otherwise agreed by KHH, KHH will not be obligated to assume any obligation of MOI under the license agreement other than the granting of the license rights consistent with the terms hereof.
